share_log

SVB Leerink Downgrades Axcella Health to Market Perform, Lowers Price Target to $2

SVB Leerink Downgrades Axcella Health to Market Perform, Lowers Price Target to $2

SVB Leerink 将Axcella Health的评级下调至市场表现,将目标价下调至2美元
Benzinga Real-time News ·  2022/12/16 06:27

SVB Leerink analyst Mike Kratky downgrades Axcella Health (NASDAQ:AXLA) from Outperform to Market Perform and lowers the price target from $6 to $2.

SVB Leerink分析师Mike·克拉基将阿克塞拉健康(纳斯达克:AXLA)的评级从表现优于大盘下调至大盘表现,并将目标价从6美元下调至2美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发